Studies of the potential utility of Ki67 as a predictive molecular marker of clinical response in primary breast cancer.
- Published Article
Breast cancer research and treatment
- Publication Date
Nov 01, 2003
Ki67 is unlikely to be useful as a predictive marker in individual patients. Further molecular markers that predict lack of response continue to be required.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 07/03/2016 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/14692655